China Medical (Germany) Top Insiders

2M7C Stock  EUR 0.86  0.03  3.61%   
China Medical employs about 5.5 K people. The company is managed by 5 executives with a total tenure of roughly 61 years, averaging almost 12.0 years of service per executive, having 1090.8 employees per reported executive. Examination of China Medical's management performance can provide insight into the company performance.
Kong Lam  Chairman
Executive Chairman of the Board, CEO and Presidentident
Yanling Chen  President
CFO, Vice President Executive Director
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Medical System. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

China Medical Management Team Effectiveness

The company has return on total asset (ROA) of 0.1324 % which means that it generated a profit of $0.1324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.243 %, meaning that it generated $0.243 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.

China Medical Workforce Comparison

China Medical System is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 148,971. China Medical holds roughly 5,454 in number of employees claiming about 4% of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of 0.36 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.37 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.37.

China Medical System Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. China Medical System Price Series Summation is a cross summation of China Medical price series and its benchmark/peer.

China Medical Notable Stakeholders

A China Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as China Medical often face trade-offs trying to please all of them. China Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting China Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kong LamExecutive Chairman of the Board, CEO and PresidentidentProfile
Yanling ChenCFO, Vice President Executive DirectorProfile
Hongbing ChenCOO, Vice President Executive DirectorProfile
Wai WongChief Technical OfficerProfile
Sanyan WuCompany SecretaryProfile

About China Medical Management Performance

The success or failure of an entity such as China Medical System often depends on how effective the management is. China Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of China management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the China management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
China Medical System Holdings Limited, an investment holding company, produces medicines and markets, promotes, and sells drugs in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. CHINA M operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3600 people.

China Medical Workforce Analysis

Traditionally, organizations such as China Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare China Medical within its industry.

China Medical Manpower Efficiency

Return on China Medical Manpower

Revenue Per Employee1.5M
Revenue Per Executive1.7B
Net Income Per Employee553.2K
Net Income Per Executive603.5M

Complementary Tools for China Stock analysis

When running China Medical's price analysis, check to measure China Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medical is operating at the current time. Most of China Medical's value examination focuses on studying past and present price action to predict the probability of China Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medical's price. Additionally, you may evaluate how the addition of China Medical to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies